CL
Clene Inc.
CLNNW · NASDAQ
$0.00 -28.00% (-$0.00)
Market Cap $2.16M
P/E Ratio -
Div. Yield -
ROE 351.16%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 10.11x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 82.24%
Net margin 14,250.50%
Op. margin 11,328.50%
Quality
30 /100
Poor ROIC 151.07%
ROE 351.16%
ROA 136.69%
Debt
66 /100
Moderate Current ratio 1.53x
Int. coverage -11.44x
Net debt/EBITDA -0.51x
Stability
55 /100
Moderate Beta 0.79x
EPS volatility 46.31%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o CLNNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Etherington
Employees
75
Headquarters
Salt Lake City